{"nctId":"NCT01301079","briefTitle":"Evaluation of the Effect of Ketamine on Remifentanil-induced Hyperalgesia","startDateStruct":{"date":"2010-09"},"conditions":["Pain","Hyperalgesia","Inflammatory Response"],"count":60,"armGroups":[{"label":"Ketamine","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Ketamine"]},{"label":"Saline","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Saline"]}],"interventions":[{"name":"Ketamine","otherNames":[]},{"name":"Saline","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* ≥ 18 years old\n* both sexes\n* ASA physical status I or II\n* undergoing laparoscopic cholecystectomy\n\nExclusion Criteria:\n\n* chronic users of analgesics or had used opioids within 12 h of surgery\n* history of drug or alcohol abuse or psychiatric disorder\n* contraindications to self-administration of opioids (ie, unable to understand the patient-controlled analgesia \\[PCA\\] device)\n* contraindication for the use of ketamine, such as a psychiatric disorder, acute cardiovascular disorder, or unstable hypertension","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"78 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"SECONDARY","title":"Time to First Morphine Supplementation","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"18","spread":null},{"groupId":"OG001","value":"15","spread":null}]}]}]},{"type":"SECONDARY","title":"Morphine Consumption Within 24 h","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"27.40","spread":"18.30"},{"groupId":"OG001","value":"27.70","spread":"12.90"}]}]}]},{"type":"SECONDARY","title":"Hyperalgesia in the Preoperative Period as Measured With Monofilaments in Thenar Eminence","description":"The pain threshold was assessed using six von Frey monofilaments (0,05 g; 0,2 g; 2 g; 4 g; 10 g e 300 g) in thenar eminence in the preoperative period. The use of different von Frey monofilaments, starting with the lightest and ending with the heaviest, was separated by at least 30 seconds to reduce any anticipated responses due to a new stimulation that was performed too soon after the preceding stimulation. Three assessments were made for each monofilament, and this was considered positive when the patient responded to two of the determinations for each monofilament.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"300","spread":"0"},{"groupId":"OG001","value":"300","spread":"0"}]}]}]},{"type":"SECONDARY","title":"Hyperalgesia in the Postoperative Period as Measured With Monofilaments in Thenar Eminence","description":"The pain threshold was assessed using six von Frey monofilaments (0,05 g; 0,2 g; 2 g; 4 g; 10 g e 300 g) in thenar eminence in the postoperative period (24 hours after procedure). The use of different von Frey monofilaments, starting with the lightest and ending with the heaviest, was separated by at least 30 seconds to reduce any anticipated responses due to a new stimulation that was performed too soon after the preceding stimulation. Three assessments were made for each monofilament, and this was considered positive when the patient responded to two of the determinations for each monofilament.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"290","spread":"54.8"},{"groupId":"OG001","value":"247","spread":"115"}]}]}]},{"type":"SECONDARY","title":"Hyperalgesia in the Preoperative Period as Measured With Monofilaments in the Periumbilical Region","description":"The pain threshold was assessed using six von Frey monofilaments (0,05 g; 0,2 g; 2 g; 4 g; 10 g e 300 g) in the periumbilical region in the preoperative period. The use of different von Frey monofilaments, starting with the lightest and ending with the heaviest, was separated by at least 30 seconds to reduce any anticipated responses due to a new stimulation that was performed too soon after the preceding stimulation. Three assessments were made for each monofilament, and this was considered positive when the patient responded to two of the determinations for each monofilament.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"279","spread":"77.1"},{"groupId":"OG001","value":"269","spread":"92"}]}]}]},{"type":"SECONDARY","title":"Hyperalgesia in the Postoperative Period as Measured With Monofilaments in the Periumbilical Region","description":"The pain threshold was assessed using six von Frey monofilaments (0,05 g; 0,2 g; 2 g; 4 g; 10 g e 300 g) in the periumbilical region in the postoperative period (24h after the procedure). The use of different von Frey monofilaments, starting with the lightest and ending with the heaviest, was separated by at least 30 seconds to reduce any anticipated responses due to a new stimulation that was performed too soon after the preceding stimulation. Three assessments were made for each monofilament, and this was considered positive when the patient responded to two of the determinations for each monofilament.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"248","spread":"114"},{"groupId":"OG001","value":"205","spread":"140"}]}]}]},{"type":"SECONDARY","title":"Hyperalgesia in the Preoperative Period as Measured With Algometer in Thenar Eminence","description":"The mechanical pain threshold was evaluated using an algometer. The pressure was increased by 0.1 kgf/second until the patient complained of pain. The mean of three determinations was calculated.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.51","spread":"1.43"},{"groupId":"OG001","value":"2.19","spread":"0.92"}]}]}]},{"type":"PRIMARY","title":"Pain 30 Minutes","description":"The scale measure pain after 30 minutes (0 - without pain and 10 worst pain possible). The individual can choose any number between 0 - 10.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.5","spread":"3.5"},{"groupId":"OG001","value":"6.2","spread":"2.6"}]}]}]},{"type":"PRIMARY","title":"Pain 60 Minutes","description":"The scale measure pain after 60 minutes (0 - without pain and 10 worst pain possible). The individual can choose any number between 0 - 10.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.6","spread":"3.0"},{"groupId":"OG001","value":"5.1","spread":"2.5"}]}]}]},{"type":"PRIMARY","title":"Pain 90 Minutes","description":"The scale measure pain after 90 minutes (0 - without pain and 10 worst pain possible). The individual can choose any number between 0 - 10.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.4","spread":"2.4"},{"groupId":"OG001","value":"3.4","spread":"2.3"}]}]}]},{"type":"PRIMARY","title":"Pain 120 Minutes","description":"The scale measure pain after 120 minutes (0 - without pain and 10 worst pain possible). The individual can choose any number between 0 - 10.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.2","spread":"2.1"},{"groupId":"OG001","value":"2.0","spread":"1.8"}]}]}]},{"type":"PRIMARY","title":"Pain 150 Minutes","description":"The scale measure pain after 150 minutes (0 - without pain and 10 worst pain possible). The individual can choose any number between 0 - 10.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.4","spread":"1.7"},{"groupId":"OG001","value":"1.4","spread":"1.6"}]}]}]},{"type":"PRIMARY","title":"Pain 180 Minutes","description":"The scale measure pain after 180 minutes (0 - without pain and 10 worst pain possible). The individual can choose any number between 0 - 10.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.1","spread":"1.5"},{"groupId":"OG001","value":"1.3","spread":"1.5"}]}]}]},{"type":"PRIMARY","title":"Pain 210 Minutes","description":"The scale measure pain after 210 minutes (0 - without pain and 10 worst pain possible). The individual can choose any number between 0 - 10.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.9","spread":"1.6"},{"groupId":"OG001","value":"1.2","spread":"1.5"}]}]}]},{"type":"PRIMARY","title":"Pain 240 Minutes","description":"The scale measure pain after 240 minutes (0 - without pain and 10 worst pain possible). The individual can choose any number between 0 - 10.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.0","spread":"1.7"},{"groupId":"OG001","value":"1.1","spread":"1.5"}]}]}]},{"type":"PRIMARY","title":"Pain 6 Hours","description":"The scale measure pain after 6 hours (0 - without pain and 10 worst pain possible). The individual can choose any number between 0 - 10.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.9","spread":"1.2"},{"groupId":"OG001","value":"0.7","spread":"1.0"}]}]}]},{"type":"PRIMARY","title":"Pain 12 Hours","description":"The scale measure pain after 12 hours (0 - without pain and 10 worst pain possible). The individual can choose any number between 0 - 10.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.6","spread":"1.8"},{"groupId":"OG001","value":"1.4","spread":"2.0"}]}]}]},{"type":"PRIMARY","title":"Pain 18 Hours","description":"The scale measure pain after 18 hours (0 - without pain and 10 worst pain possible). The individual can choose any number between 0 - 10.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.5","spread":"1.8"},{"groupId":"OG001","value":"1.3","spread":"1.6"}]}]}]},{"type":"PRIMARY","title":"Pain 24 Hours","description":"The scale measure pain after 24 hours (0 - without pain and 10 worst pain possible). The individual can choose any number between 0 - 10.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.4","spread":"1.5"},{"groupId":"OG001","value":"0.8","spread":"1.0"}]}]}]},{"type":"SECONDARY","title":"Hyperalgesia in the Postoperative Period as Measured With Algometer in Thenar Eminence","description":"The mechanical pain threshold was evaluated using an algometer. The pressure was increased by 0.1 kgf/second until the patient complained of pain. The mean of three determinations was calculated.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.56","spread":"0.44"},{"groupId":"OG001","value":"0.51","spread":"0.44"}]}]}]},{"type":"SECONDARY","title":"Hyperalgesia in the Preoperative Period as Measured With Algometer in the Periumbilical Region","description":"The mechanical pain threshold was evaluated using an algometer. The pressure was increased by 0.1 kgf/second until the patient complained of pain. The mean of three determinations was calculated.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.6","spread":"1.5"},{"groupId":"OG001","value":"3.9","spread":"1.4"}]}]}]},{"type":"SECONDARY","title":"Hyperalgesia in the Postoperative Period as Measured With Algometer in the Periumbilical Region","description":"The mechanical pain threshold was evaluated using an algometer. The pressure was increased by 0.1 kgf/second until the patient complained of pain. The mean of three determinations was calculated.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.5","spread":"1.6"},{"groupId":"OG001","value":"3.7","spread":"1.7"}]}]}]},{"type":"SECONDARY","title":"Extension of Hyperalgesia","description":"The 300-g filament was used 24 hours after the operation to induce a stimulus and delineate the extent of hyperalgesia from the periumbilical region. The stimulus was started outside the periumbilical region, where no pain sensation was reported, and continued every 0.5 cm until the 4 points of the periumbilical scar were reached (top, right side, left side, and bottom). The first point where the patient complained of pain was marked. If no pain sensation was reported, the stimulus was terminated 0.5 cm from the incision. The distance of each point from the surgical incision was measured, and the sum of the distances of the points was determined.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10.61","spread":"8.63"},{"groupId":"OG001","value":"11.82","spread":"8.36"}]}]}]},{"type":"SECONDARY","title":"Allodynia as Detected With a Soft Brush in the Periumbilical Region Before the Procedure","description":"The evaluations using the soft brush were performed 2-3 cm from the incision in the periumbilical region (where the large trocar was placed) before the procedure","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Allodynia as Detected With a Soft Brush in the Periumbilical Region 24 h After the Procedure","description":"The evaluations using the soft brush were performed 2-3 cm from the incision in the periumbilical region (where the large trocar was placed) 24 h after the procedure","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Allodynia as Detected With a Soft Brush in the Thenar Eminence Before the Procedure","description":"The evaluations using the soft brush were performed in the thenar eminence of the nondominant hand before the procedure","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Allodynia as Detected With a Soft Brush in the Thenar Eminence 24 h After the Procedure","description":"The evaluations using the soft brush were performed in the thenar eminence of the non dominant hand 24 h after the procedure","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]}]},{"type":"SECONDARY","title":"Serum Level of Interleukin (IL)-6 Before the Procedure","description":"Blood samples were drawn in ethylenediaminetetraacetic acid (EDTA) tubes before the surgery. The blood was centrifuged to separate the plasma and was stored at -70°C. IL-6 was analyzed using the enzyme-linked immunosorbent assay (ELISA) methodology.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.3","spread":"9.5"},{"groupId":"OG001","value":"2.1","spread":"3.4"}]}]}]},{"type":"SECONDARY","title":"Serum Level of Interleukin (IL)-6 5 h After the Procedure","description":"Blood samples were drawn in ethylenediaminetetraacetic acid (EDTA) tubes 5 h after the surgery. The blood was centrifuged to separate the plasma and was stored at -70°C. IL-6 was analyzed using the enzyme-linked immunosorbent assay (ELISA) methodology.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"29.3","spread":"23.6"},{"groupId":"OG001","value":"34.8","spread":"48.7"}]}]}]},{"type":"SECONDARY","title":"Serum Level of Interleukin (IL)-6 24 h After the Procedure","description":"Blood samples were drawn in ethylenediaminetetraacetic acid (EDTA) tubes 24 h after the surgery. The blood was centrifuged to separate the plasma and was stored at -70°C. IL-6 was analyzed using the enzyme-linked immunosorbent assay (ELISA) methodology.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"24.1","spread":"21.3"},{"groupId":"OG001","value":"24.8","spread":"31.5"}]}]}]},{"type":"SECONDARY","title":"Serum Level of Interleukin (IL)-8 Before the Procedure","description":"Blood samples were drawn in ethylenediaminetetraacetic acid (EDTA) tubes before the surgery. The blood was centrifuged to separate the plasma and was stored at -70°C. IL-8 was analyzed using the enzyme-linked immunosorbent assay (ELISA) methodology.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.3","spread":"4.1"},{"groupId":"OG001","value":"2.2","spread":"3.2"}]}]}]},{"type":"SECONDARY","title":"Serum Level of Interleukin (IL)-8 5 h After the Procedure","description":"Blood samples were drawn in ethylenediaminetetraacetic acid (EDTA) tubes 5 h after the surgery. The blood was centrifuged to separate the plasma and was stored at -70°C. IL-8 was analyzed using the enzyme-linked immunosorbent assay (ELISA) methodology.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8.0","spread":"6.8"},{"groupId":"OG001","value":"11.3","spread":"15.1"}]}]}]},{"type":"SECONDARY","title":"Serum Level of Interleukin (IL)-8 24 h After the Procedure","description":"Blood samples were drawn in ethylenediaminetetraacetic acid (EDTA) tubes 24 h after the surgery. The blood was centrifuged to separate the plasma and was stored at -70°C. IL-8 was analyzed using the enzyme-linked immunosorbent assay (ELISA) methodology.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.0","spread":"7.2"},{"groupId":"OG001","value":"4.5","spread":"6.1"}]}]}]},{"type":"SECONDARY","title":"Serum Level of Interleukin (IL)-10 Before the Procedure","description":"Blood samples were drawn in ethylenediaminetetraacetic acid (EDTA) tubes before the surgery. The blood was centrifuged to separate the plasma and was stored at -70°C. IL-6 was analyzed using the enzyme-linked immunosorbent assay (ELISA) methodology.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7.8","spread":"20"},{"groupId":"OG001","value":"1.9","spread":"3.3"}]}]}]},{"type":"SECONDARY","title":"Serum Level of Interleukin (IL)-10 5h After the Procedure","description":"Blood samples were drawn in ethylenediaminetetraacetic acid (EDTA) tubes 5 h after the surgery. The blood was centrifuged to separate the plasma and was stored at -70°C. IL-10 was analyzed using the enzyme-linked immunosorbent assay (ELISA) methodology.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9.1","spread":"19.1"},{"groupId":"OG001","value":"5.5","spread":"7.9"}]}]}]},{"type":"SECONDARY","title":"Serum Level of Interleukin (IL)-10 24 h After the Procedure","description":"Blood samples were drawn in ethylenediaminetetraacetic acid (EDTA) tubes 24 h after the surgery. The blood was centrifuged to separate the plasma and was stored at -70°C. IL-6 was analyzed using the enzyme-linked immunosorbent assay (ELISA) methodology.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8.6","spread":"18.5"},{"groupId":"OG001","value":"5.0","spread":"5.5"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":28},"commonTop":["Vomiting","Diplopia/nystagmus"]}}}